title: CABG or PCI: which is better for revascularization of coronary artery disease in chronic kidney disease?
abstract: Chronic kidney disease (CKD) is a potent risk factor for coronary artery disease and premature death. However, the optimal strategies for revascularization versus medical management remain unclear. Charytan et al. address this knowledge gap with a well-structured individual patient meta-analysis. We discuss the implications of their findings for patients with moderate CKD and highlight the need for randomized, controlled trials on this issue in more severe CKD.
authors.affiliation: University of Manitoba and Chronic Disease Innovation Centre, Seven Oaks Hospital, Winnipeg, Manitoba, Canada. Electronic address: crigatto@sbgh.mb.ca.
authors.forename: Claudio
authors.initials: C
authors.lastname: Rigatto
authors.affiliation: University of Manitoba and Chronic Disease Innovation Centre, Seven Oaks Hospital, Winnipeg, Manitoba, Canada.
authors.forename: Paul
authors.initials: P
authors.lastname: Komenda
authors.affiliation: University of Manitoba and Chronic Disease Innovation Centre, Seven Oaks Hospital, Winnipeg, Manitoba, Canada.
authors.forename: Navdeep
authors.initials: N
authors.lastname: Tangri
mesh_terms: D001026:Coronary Artery Bypass; D003324:Coronary Artery Disease; D006801:Humans; D062645:Percutaneous Coronary Intervention; D051436:Renal Insufficiency, Chronic; D016896:Treatment Outcome